Akgül Erdal, M. Et Al. 2023. P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey. ECFS Conference 2023 , (Vienna, Austria).

Akgül Erdal, M., Nayır Büyükşahin, H., Şen, V., Kılınç, A. A., Çokuğraş, H. C., Doğan Demir, A., ... Doğan, G.(2023). P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey . ECFS Conference 2023, Vienna, Austria

Akgül Erdal, Meltem Et Al. "P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey," ECFS Conference 2023, Vienna, Austria, 2023

Akgül Erdal, Meltem A. Et Al. "P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey." ECFS Conference 2023 , Vienna, Austria, 2023

Akgül Erdal, M. Et Al. (2023) . "P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey." ECFS Conference 2023 , Vienna, Austria.

@conferencepaper{conferencepaper, author={Meltem Akgül Erdal Et Al. }, title={P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey}, congress name={ECFS Conference 2023}, city={Vienna}, country={Austria}, year={2023}}